Abstract
Charcot arthropathy is a challenging disease process to manage. Major lower extremity amputation is often the end-line treatment. However, special consideration must be taken during amputation of a Charcot’s limb because the hypervascularity and edema unique to these patients can be an obstacle to proper wound healing and subsequent independence on a prosthetic. We will discuss here staged amputation that takes into account the pathophysiology of Charcot arthropathy by incorporating negative pressure wound therapy (NPWT) into the wound-healing process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rogers LC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, Van GH, et al. The Charcot foot in diabetes. Diabetes Care. 2011;34(9):2123–9. https://doi.org/10.2337/dc11–0844.
Alrashidi Y, Hugle T, Wiewiorski M, Herrera-Perez M, Valderrabano V. Surgical treatment options for the diabetic Charcot midfoot deformity. Clin Podiatr Med Surg. 2017;34(1):43–51. https://doi.org/10.1016/j.cpm.2016.07.006.
Ettinger S, Stukenborg-Colsman C, Plaass C, Yao D, Claassen L, Berger S, et al. Tibiocalcaneal arthrodesis as a limb salvage procedure for complex hindfoot deformities. Arch Orthop Trauma Surg. 2016;136(4):457–62. https://doi.org/10.1007/s00402–016–2420–1.
Stapleton JJ, Zgonis T. Surgical reconstruction of the diabetic Charcot foot: internal, external or combined fixation? Clin Podiatr Med Surg. 2012;29(3):425–33. https://doi.org/10.1016/j.cpm.2012.04.003.
Schneekloth BJ, Lowery NJ, Wukich DK. Charcot neuroarthropathy in patients with diabetes: an updated systematic review of surgical management. J Foot Ankle Surg. 2016;55(3):586–90. https://doi.org/10.1053/j.jfas.2015.12.001.
La Fontaine J, Lavery L, Jude E. Current concepts of Charcot foot in diabetic patients. Foot (Edinb). 2016;26:7–14. https://doi.org/10.1016/j.foot.2015.11.001.
Ramanujam CL, Han D, Zgonis T. Lower extremity amputation and mortality rates in the reconstructed diabetic Charcot foot and ankle with external fixation: data analysis of 116 patients. Foot Ankle Spec. 2016;9(2):113–26. https://doi.org/10.1177/1938640015599036.
Wukich DK, Sadoskas D, Vaudreuil NJ, Fourman M. Comparison of diabetic Charcot patients with and without foot wounds. Foot Ankle Int. 2017;38(2):140–8. https://doi.org/10.1177/1071100716673985.
Lee L, Blume PA, Sumpio B. Charcot joint disease in diabetes mellitus. Ann Vasc Surg. 2003;17(5):571–80. https://doi.org/10.1007/s10016–003–0039–5.
Donegan R, Sumpio B, Blume PA. Charcot foot and ankle with osteomyelitis. Diabet Foot Ankle. 2013;4(1):21361. https://doi.org/10.3402/dfa.v4i0.21361.
Blume PA, Sumpio B, Schmidt B, Donegan R. Charcot neuroarthropathy of the foot and ankle: diagnosis and management strategies. Clin Podiatr Med Surg. 2014;31(1):151–72. https://doi.org/10.1016/j.cpm.2013.09.007.
Koeck FX, Bobrik V, Fassold A, Grifka J, Kessler S, Straub RH. Marked loss of sympathetic nerve fibers in chronic Charcot foot of diabetic origin compared to ankle joint osteoarthritis. J Orthop Res. 2009;27(6):736–41. https://doi.org/10.1002/jor.20807.
Sanders LJ. The Charcot foot: historical perspective 1827–2003. Diabetes Metab Res Rev. 2004;20(Suppl 1):S4–8. https://doi.org/10.1002/dmrr.451.
Chantelau E, Onvlee GJ. Charcot foot in diabetes: farewell to the neurotrophic theory. Horm Metab Res. 2006;38(6):361–7. https://doi.org/10.1055/s-2006–944525.
Trieb K, Hofstatter SG. Pathophysiology and etiology of the Charcot foot. Der Orthopade. 2015;44(1):2–7. https://doi.org/10.1007/s00132–014–3049–9.
Uccioli L, Sinistro A, Almerighi C, Ciaprini C, Cavazza A, Giurato L, et al. Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot. Diabetes Care. 2010;33(2):350–5. https://doi.org/10.2337/dc09–1141.
Akopian A, Demulder A, Ouriaghli F, Corazza F, Fondu P, Bergmann P. Effects of CGRP on human osteoclast-like cell formation: a possible connection with the bone loss in neurological disorders. Peptides. 2000;21(4):559–64.
La Fontaine J, Harkless LB, Sylvia VL, Carnes D, Heim-Hall J, Jude E. Levels of endothelial nitric oxide synthase and calcitonin gene-related peptide in the Charcot foot: a pilot study. J Foot Ankle Surg. 2008;47(5):424–9. https://doi.org/10.1053/j.jfas.2008.05.009.
Kaynak G, Birsel O, Guven MF, Ogut T. An overview of the Charcot foot pathophysiology. Diabet Foot Ankle. 2013;4(1):21117. https://doi.org/10.3402/dfa.v4i0.21117.
Jeffcoate WJ. Charcot neuro-osteoarthropathy. Diabetes Metab Res Rev. 2008;24(Suppl 1):S62–5. https://doi.org/10.1002/dmrr.837.
Shapiro SA, Stansberry KB, Hill MA, Meyer MD, McNitt PM, Bhatt BA, et al. Normal blood flow response and vasomotion in the diabetic Charcot foot. J Diabetes Complicat. 1998;12(3):147–53.
Baker N, Green A, Krishnan S, Rayman G. Microvascular and C-fiber function in diabetic charcot neuroarthropathy and diabetic peripheral neuropathy. Diabetes Care. 2007;30(12):3077–9. https://doi.org/10.2337/dc07–1063.
Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002;45(8):1085–96. https://doi.org/10.1007/s00125–002–0885–7.
Sumpio B, Thakor P, Mahler D, Blume P. Negative pressure wound therapy as postoperative dressing in below knee amputation stump closure of patients with chronic venous insufficiency. Wounds. 2011;23(10):301–8.
Orgill DP, Manders EK, Sumpio BE, Lee RC, Attinger CE, Gurtner GC, et al. The mechanisms of action of vacuum assisted closure: more to learn. Surgery. 2009;146(1):40–51. https://doi.org/10.1016/j.surg.2009.02.002.
Morykwas MJ, Argenta LC, Shelton-Brown EI, McGuirt W. Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann Plast Surg. 1997;38(6):553–62.
Argenta LC, Morykwas MJ. Vacuum-assisted closure: a new method for wound control and treatment: clinical experience. Ann Plast Surg. 1997;38(6):563–76. discussion 577
Tanaka T, Panthee N, Itoda Y, Yamauchi N, Fukayama M, Ono M. Negative pressure wound therapy induces early wound healing by increased and accelerated expression of vascular endothelial growth factor receptors. Eur J Plast Surg. 2016;39:247–56. https://doi.org/10.1007/s00238–016–1200-z.
Yang SL, Han R, Liu Y, Hu LY, Li XL, Zhu LY. Negative pressure wound therapy is associated with up-regulation of bFGF and ERK1/2 in human diabetic foot wounds. Wound Repair Regen. 2014;22(4):548–54. https://doi.org/10.1111/wrr.12195.
Folsom D, King T, Rubin JR. Lower-extremity amputation with immediate postoperative prosthetic placement. Am J Surg. 1992;164(4):320–2.
Ali MM, Loretz L, Shea A, Poorvu E, Robinson WP, Schanzer A, et al. A contemporary comparative analysis of immediate postoperative prosthesis placement following below-knee amputation. Ann Vasc Surg. 2013;27(8):1146–53. https://doi.org/10.1016/j.avsg.2012.10.031.
Schon LC, Short KW, Soupiou O, Noll K, Rheinstein J. Benefits of early prosthetic management of transtibial amputees: a prospective clinical study of a prefabricated prosthesis. Foot Ankle Int. 2002;23(6):509–14.
Sumpio B, Shine SR, Mahler D, Sumpio BE. A comparison of immediate postoperative rigid and soft dressings for below-knee amputations. Ann Vasc Surg. 2013;27(6):774–80. https://doi.org/10.1016/j.avsg.2013.03.007.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chen, J.F., Sumpio, B.E. (2019). Strategies for Leg Amputation in Patients with Charcot’s Arthropathy. In: Edmonds, M., Sumpio, B. (eds) Limb Salvage of the Diabetic Foot. Springer, Cham. https://doi.org/10.1007/978-3-319-17918-6_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-17918-6_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-17917-9
Online ISBN: 978-3-319-17918-6
eBook Packages: MedicineMedicine (R0)